Complete balanced ONS is estimated at 38.9% by product type in 2026, with inpatient & residential care at 39.7% and anorexia nervosa at 46.9% of diagnosis demand. Clinician-set energy goals favor repeatable oral formats despite refeeding risk, tolerance, and reimbursement limits on unsupervised substitution.